12 completed, 3 terminated, 3 unknown, 1 not yet recruiting. 19 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 19 | Completed 12, Terminated 3, Unknown 3, Not yet recruiting 1 |
Follow Orlistat: new trials by email Literature Review of Orlistat trials Research Report on Orlistat
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| RWS of of Liraglutide Alone and in Combination With Orlistat for Weight Loss in Overweight/Obese Patients. liraglutide monotherapy, liraglutide combined with orlistat - Overweight and Obese Adults | Phase 4 | Not yet recruiting | The Fourth Affiliated Hospital of Zhejiang University School of Medicine | 120 | 2026-05-01 | 2026-03-23 |
| Efficacy and Safety of Liraglutide in the Treatment of Obesity Combined With Metabolism Associated Fatty Liver Disease Liraglutide, Orlistat - Non-alcoholic Fatty Liver Disease, Obesity | Phase 4 | Unknown | Affiliated Hospital of Nantong University | 102 | 2023-11-01 | 2024-07-15 |
| A Research Study Comparing Wegovy to Other Weight Management Drugs in People Living With Obesity in America Semaglutide, Orlistat, Phentermine/Topiramate - Obesity | Phase 4 | Completed | Novo Nordisk A/S | 500 | 2023-01-19 | 2026-01-14 |
| Orlistat Reduces Uric Acid in Overweight/Obese Patients With Hyperuricemia Orlistat, Orlistat placebo - Uric Acid | Phase 4 | Completed | Shanghai 10th People's Hospital | 72 | 2022-08-26 | 2023-12-14 |
| EMI-EHP Weight Management and Type 2 Diabetes Pragmatic Trial Weight Management Program (WMP), Traditional care, Phentermine / Topiramate Extended Release Oral Capsule - Type 2 Diabetes, Obesity | Phase 4 | Terminated | The Cleveland Clinic | 74 | 2020-09-01 | 2024-09-19 |
| Weight Loss Aid in an Exposed Population Orlistat, Placebo capsule, Multivitamin - Polybrominated Biphenyl Poisoning | Phase 4 | Completed | Emory University | 100 | 2018-09-14 | 2026-10-20 |
| Research of Intensive Metabolic Intervention Before Pregnancy in PCOS Acarbose 100 MG, Exenatide, Orlistat - PCOS, Impaired Glucose Tolerance | Phase 4 | Unknown | RenJi Hospital | 160 | 2018-01-01 | 2017-12-26 |
| Roux-en-Y Gastric Bypass for BMI 27-32 Type 2 Diabetes Versus Best Medical Treatment Roux-en-Y Gastric Bypass (RYGB), Incretin analogues, Xenical - Type II Diabetes in Subjects BMI 27 to 32 | Phase 4 | Completed | Khoo Teck Puat Hospital | 40 | 2014-02-01 | 2022-06-23 |
| Combinatorial Therapy for Peristent Type 2 Diabetes After Gastric Banding Liraglutide, Orlistat, Liraglutide + Orlistat - Type 2 Diabetes, Gastric Banding | Phase 4 | Terminated | East Carolina University | 1 | 2012-06-01 | 2018-02-05 |
| A Pilot Study of the Efficacy of Alli in the Management of Pre-operative Weight Loss Required for Bariatric Surgery. Orlistat - Obesity | Phase 4 | Completed | Albany College of Pharmacy and Health Sciences | 19 | 2009-11-01 | 2014-04-04 |
| Effect of Orlistat in Body Composition Orlistat, Placebo - Obesity, Overweight | Phase 4 | Completed | GlaxoSmithKline | 131 | 2008-09-01 | 2013-03-08 |
| Study of Behavioral Weight Loss Therapy for Obesity and Binge Eating in Monolingual Hispanic Persons Xenical + behavioral intervention, Behavioral intervention + placebo - Obesity, Binge Eating | Phase 4 | Completed | Yale University | 79 | 2007-08-01 | 2020-04-02 |
| Study for the Treatment of Significant Steatosis With Xenical Followed by Treatment of Hepatitis C With Pegasys/Copegus Xenical, Pegasys, Copegus, Xenicare Program - Fatty Liver, Hepatitis C | Phase 4 | Completed | Brooke Army Medical Center | 30 | 2005-08-01 | 2012-02-14 |
| LOSS- Louisiana Obese Subjects Study group sessions, sibutramine, orlistat, diethylpropion, Low Calorie Diet, Health One - Obesity | Phase 4 | Terminated | Pennington Biomedical Research Center | 390 | 2005-07-01 | 2016-02-22 |
| The Effect of Xenical on Weight and Risk Factors Orlistat - Obesity, Heart Diseases | Phase 4 | Completed | University of British Columbia | 25 | 2005-06-01 | 2013-04-01 |
| The Effect of Weight Loss on Anti-Müllerian Hormone Levels in Women With Polycystic Ovary Syndrome (PCOS) Orlistat, Sibutramine, Diet and physical exercise - Obesity, Polycystic Ovaries Syndrome | Phase 4 | Unknown | Aristotle University Of Thessaloniki | 200 | 2004-01-01 | 2011-11-21 |
| Orlistat (Xenical) in the Treatment of Overweight Patients With Nonalcoholic Steatohepatitis (NASH) Orlistat (Xenical), 1400 kcal diet (30% fat) - Fatty Liver, Hepatitis | Phase 4 | Completed | St. Louis University | 50 | 2003-10-01 | 2007-11-20 |
| Multifactorial Approach Associated With Orlistat (Xenical) for 4 Years Weight Loss Maintenance in Obese Adults Orlistat - Obesity | Phase 4 | Completed | Hoffmann-La Roche | 50 | 2002-07-01 | 2016-04-05 |
| Effectiveness of Brief Counseling for Weight Management orlistat, Brief cognitive behavioral counseling - 1. Obesity | Phase 4 | Completed | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 246 | 2002-01-01 | 2010-03-18 |
Obesity (11) · Diabetes Mellitus, Type 2 (2) · Fatty Liver (2) · Insulin Resistance (2) · Non-alcoholic Fatty Liver Disease (2) · Overweight (2) · Bulimia (1) · Diabetes Mellitus (1) · Glucose Intolerance (1) · Heart Diseases (1) · Hepatitis (1) · Hepatitis C (1) · Weight Loss (1)
Affiliated Hospital of Nantong University (1) · Albany College of Pharmacy and Health Sciences (1) · Aristotle University Of Thessaloniki (1) · Brooke Army Medical Center (1) · East Carolina University (1) · Emory University (1) · GlaxoSmithKline (1) · Hoffmann-La Roche (1) · Khoo Teck Puat Hospital (1) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1) · Novo Nordisk A/S (1) · Pennington Biomedical Research Center (1) · RenJi Hospital (1) · Shanghai 10th People's Hospital (1) · St. Louis University (1)
United States (11) · China (3) · Canada (1) · Greece (1) · Singapore (1) · Sweden (1) · Switzerland (1)
Anton Cheng, MBBS (1) · Bartolome Burguera (1) · Brent A Tetri, MD (1) · Carlos M Grilo, PhD (1) · Dimitrios Panidis, PhD (1) · Donna H Ryan, MD (1) · GU Yunjuan, doctor (1) · Jiri Frohlich, MD (1) · John P Foreyt, PhD (1) · Margaret Malone, PhD (1) · Michele Marcus, PhD, MPH (1) · Stephen A Harrison, MD (1)
PMID 19053049, PMID 20101009, PMID 21962313, PMID 23376451, PMID 34582624, PMID 35513159, PMID 38468241, PMID 42746240
R01ES025775 (1)